176 related articles for article (PubMed ID: 28340587)
1. Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice.
Winkler CW; Myers LM; Woods TA; Carmody AB; Taylor KG; Peterson KE
J Neuroinflammation; 2017 Mar; 14(1):62. PubMed ID: 28340587
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
[TBL] [Abstract][Full Text] [Related]
3. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
[TBL] [Abstract][Full Text] [Related]
4. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
Schuh T; Schultz J; Moelling K; Pavlovic J
Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
[TBL] [Abstract][Full Text] [Related]
5. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
[TBL] [Abstract][Full Text] [Related]
6. The CARD9-Associated C-Type Lectin, Mincle, Recognizes La Crosse Virus (LACV) but Plays a Limited Role in Early Antiviral Responses against LACV.
Monteiro JT; Schön K; Ebbecke T; Goethe R; Ruland J; Baumgärtner W; Becker SC; Lepenies B
Viruses; 2019 Mar; 11(3):. PubMed ID: 30917612
[TBL] [Abstract][Full Text] [Related]
7. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
[TBL] [Abstract][Full Text] [Related]
8. Identification of age-specific gene regulators of La Crosse virus neuroinvasion and pathogenesis.
Basu R; Ganesan S; Winkler CW; Anzick SL; Martens C; Peterson KE; Fraser IDC
Nat Commun; 2023 May; 14(1):2836. PubMed ID: 37202395
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of infectivity of insect cell-derived La Crosse Virus by human serum.
Cruz MA; Parks GD
Virus Res; 2021 Jan; 292():198228. PubMed ID: 33188797
[TBL] [Abstract][Full Text] [Related]
10. Innate immune response to La Crosse virus infection.
Taylor KG; Peterson KE
J Neurovirol; 2014 Apr; 20(2):150-6. PubMed ID: 23846288
[TBL] [Abstract][Full Text] [Related]
11. Capillaries in the olfactory bulb but not the cortex are highly susceptible to virus-induced vascular leak and promote viral neuroinvasion.
Winkler CW; Race B; Phillips K; Peterson KE
Acta Neuropathol; 2015 Aug; 130(2):233-45. PubMed ID: 25956408
[TBL] [Abstract][Full Text] [Related]
12. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
[TBL] [Abstract][Full Text] [Related]
13. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
Virol J; 2007 May; 4():41. PubMed ID: 17488515
[TBL] [Abstract][Full Text] [Related]
14. Effects of La Crosse virus infection on pregnant domestic rabbits and mongolian gerbils.
Osorio JE; Schoepp RJ; Yuill TM
Am J Trop Med Hyg; 1996 Oct; 55(4):384-90. PubMed ID: 8916793
[TBL] [Abstract][Full Text] [Related]
15. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
J Virol; 2023 Aug; 97(8):e0081923. PubMed ID: 37578236
[TBL] [Abstract][Full Text] [Related]
16. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
Blakqori G; Delhaye S; Habjan M; Blair CD; Sánchez-Vargas I; Olson KE; Attarzadeh-Yazdi G; Fragkoudis R; Kohl A; Kalinke U; Weiss S; Michiels T; Staeheli P; Weber F
J Virol; 2007 May; 81(10):4991-9. PubMed ID: 17344298
[TBL] [Abstract][Full Text] [Related]
17. Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.
Dawes BE; Gao J; Atkins C; Nelson JT; Johnson K; Wu P; Freiberg AN
J Neuroinflammation; 2018 Nov; 15(1):315. PubMed ID: 30442185
[TBL] [Abstract][Full Text] [Related]
18. Possible congenital infection with La Crosse encephalitis virus--West Virginia, 2006-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):4-7. PubMed ID: 19145220
[TBL] [Abstract][Full Text] [Related]
19. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice.
Kallfass C; Ackerman A; Lienenklaus S; Weiss S; Heimrich B; Staeheli P
J Virol; 2012 Oct; 86(20):11223-30. PubMed ID: 22875966
[TBL] [Abstract][Full Text] [Related]
20. Tahyna virus genetics, infectivity, and immunogenicity in mice and monkeys.
Bennett RS; Gresko AK; Murphy BR; Whitehead SS
Virol J; 2011 Mar; 8():135. PubMed ID: 21435229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
